Josep V. Forment

3.9k citations

30 papers · 2.1k indexed · 1 hit paper · h-index 18

Molecular Biology top 5%
Oncology top 5%
Cell Biology top 5%
Cancer Research top 10%
Genetics top 10%

Co-authors: Stephen P. Jackson Abderrahmane Kaidi Mark J. O’Connor Sébastien Britton Raphaël Rodriguez Blerta Xhemalçe Charles R. Bradshaw Mehran Nikan
Topics: DNA Repair Mechanisms (18 papers)PARP inhibition in cancer therapy (12 papers)CRISPR and Genetic Engineering (8 papers)
Cited by: Molecular Biology Aging Oncology
Journals: Nucleic Acids Research Journal of Biological Chemistry Nature Communications
Partner nations: United Kingdom Spain Singapore

In The Last Decade

Josep V. Forment

28 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Small-molecule–induced DNA damage identifies alternative DNA structures in human genes

2012 589 citations Raphaël Rodriguez, Kyle M. Miller et al. Nature Chemical Biology profile →

Peers

Countries citing papers authored by Josep V. Forment

Since Specialization

Citations

This map shows the geographic impact of Josep V. Forment's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josep V. Forment with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josep V. Forment more than expected).

Fields of papers citing papers by Josep V. Forment

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josep V. Forment. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josep V. Forment. The network helps show where Josep V. Forment may publish in the future.

Co-authorship network of co-authors of Josep V. Forment

This figure shows the co-authorship network connecting the top 25 collaborators of Josep V. Forment. A scholar is included among the top collaborators of Josep V. Forment based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josep V. Forment. Josep V. Forment is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Androgen receptor inhibition extends PARP inhibitor activity in prostate cancer models beyond BRCA mutations and defects in homologous recombination repair 2025 ·NAR Cancer ·Giuditta Illuzzi,Alessandro Galbiati,Anna D. Staniszewska,Robert L. Hanson,Chrysiis Michaloglou,(unknown),(unknown),(unknown),(unknown),Harveer Dev,Charles Massie,Mark R. Albertella,Elisabetta Leo,Josep V. Forment,Mark J. O’Connor	0
2	Site-selective photo-crosslinking for the characterisation of transient ubiquitin-like protein-protein interactions 2025 ·PLoS ONE ·(unknown),Zijuan Wang,Deepak Behera,Benjamin M. Foster,Francisco Martı́n,(unknown),(unknown),Wolfgang Dörner,(unknown),Josep V. Forment,Matthew J. Cliff,Igor Larrosa,Perdita E. Barran,Duncan L. Smith,Henning D. Mootz,Christine K. Schmidt	0
3	Understanding tumour growth variability in breast cancer xenograft models identifies PARP inhibition resistance biomarkers 2024 ·npj Precision Oncology ·(unknown),Josep V. Forment,(unknown),Dimitris Polychronopoulos,(unknown),Andreas Bender,Violeta Serra,Mark J. O’Connor,James Yates,Krishna C. Bulusu	2
4	C16orf72/HAPSTR1/TAPR1 functions with BRCA1/Senataxin to modulate replication-associated R-loops and confer resistance to PARP disruption 2023 ·Nature Communications ·Abhishek Sharma,Muhammad Khairul Ramlee,(unknown),Martin R. Higgs,(unknown),George E. Ronson,Dylan Jones,Daniel Ebner,(unknown),David Sims,Paul W.G. Wijnhoven,Josep V. Forment,Ian Gibbs‐Seymour,Nicholas D. Lakin	5
5	Drug–gene Interaction Screens Coupled to Tumor Data Analyses Identify the Most Clinically Relevant Cancer Vulnerabilities Driving Sensitivity to PARP Inhibition 2022 ·Cancer Research Communications ·(unknown),Alessandro Galbiati,Joshua Armenia,Giuditta Illuzzi,James Hall,(unknown),Daniel Barrell,Miika Ahdesmäki,Mark J. O’Connor,Elisabetta Leo,Josep V. Forment	11
6	Loss of Cyclin C or CDK8 provides ATR inhibitor resistance by suppressing transcription-associated replication stress 2021 ·Nucleic Acids Research ·(unknown),(unknown),Francisco Muñoz‐Martínez,(unknown),(unknown),Christelle de Renty,Mark J. O’Connor,Josep V. Forment,Yaron Galanty,Stephen P. Jackson	35
7	A meta-analysis of reversion mutations in BRCA genes identifies signatures of DNA end-joining repair mechanisms driving therapy resistance 2020 ·Annals of Oncology ·Luis Tobalina,Joshua Armenia,(unknown),Mark J. O’Connor,Josep V. Forment	114
8	Derivation and maintenance of mouse haploid embryonic stem cells 2019 ·Nature Protocols ·Ulrich Elling,Michael Woods,Josep V. Forment,Beiyuan Fu,Fengtang Yang,Bee Ling Ng,(unknown),David J. Adams,Brendan Doe,Stephen P. Jackson,Josef Penninger,Gabriel Balmus	15
9	XenofilteR: computational deconvolution of mouse and human reads in tumor xenograft sequence data 2018 ·BMC Bioinformatics ·Roelof J.C. Kluin,Kristel Kemper,Thomas Kuilman,Julian R. de Ruiter,Vivek Iyer,Josep V. Forment,Paulien Cornelissen‐Steijger,Iris de Rink,Petra ter Brugge,Ji‐Ying Song,Sjoerd Klarenbeek,Ultan McDermott,Jos Jonkers,Arno Velds,David J. Adams,Daniel S. Peeper,Oscar Krijgsman	72
10	Targeting the replication stress response in cancer 2018 ·Pharmacology & Therapeutics ·Josep V. Forment,Mark J. O’Connor	112
11	Detection of functional protein domains by unbiased genome-wide forward genetic screening 2018 ·Scientific Reports ·Mareike Herzog,Fabio Puddu,Julia Coates,(unknown),Josep V. Forment,Stephen P. Jackson	12
12	Genome-wide genetic screening with chemically mutagenized haploid embryonic stem cells 2016 ·Nature Chemical Biology ·Josep V. Forment,Mareike Herzog,Julia Coates,Tomasz Konopka,Bianca V. Gapp,Sebastian Nijman,David J. Adams,Thomas Keane,Stephen P. Jackson	30
13	A flow cytometry–based method to simplify the analysis and quantification of protein association to chromatin in mammalian cells 2015 ·Nature Protocols ·Josep V. Forment,Stephen P. Jackson	56
14	Small-molecule–induced DNA damage identifies alternative DNA structures in human genesbreakdown → 2012 ·Nature Chemical Biology ·Raphaël Rodriguez,Kyle M. Miller,Josep V. Forment,Charles R. Bradshaw,Mehran Nikan,Sébastien Britton,(unknown),Blerta Xhemalçe,Shankar Balasubramanian,Stephen P. Jackson	589
15	A high‐throughput, flow cytometry‐based method to quantify DNA‐end resection in mammalian cells 2012 ·Cytometry Part A ·Josep V. Forment,Rachael Walker,Stephen P. Jackson	63
16	A phospho-proteomic screen identifies substrates of the checkpoint kinase Chk1 2011 ·Genome biology ·Melanie Blasius,Josep V. Forment,(unknown),Sebastian Wagner,Chunaram Choudhary,Stephen P. Jackson	113
17	Structure-Specific DNA Endonuclease Mus81/Eme1 Generates DNA Damage Caused by Chk1 Inactivation 2011 ·PLoS ONE ·Josep V. Forment,Melanie Blasius,Ilaria Guerini,Stephen P. Jackson	90
18	Concentration dependent effects of commonly used pesticides on activation versus inhibition of the quince (Cydonia Oblonga) polyphenol oxidase 2010 ·Food and Chemical Toxicology ·Sami Fattouch,(unknown),José Vicente Gil,Josep V. Forment,Dunja Lukovic,Mohamed Néjib Marzouki,Daniel Ramón	15
19	Identification of the mstE Gene Encoding a Glucose-inducible, Low Affinity Glucose Transporter in Aspergillus nidulans 2006 ·Journal of Biological Chemistry ·Josep V. Forment,Michel Flipphi,Daniel Ramón,(unknown),Andrew MacCabe	36
20	Consecutive gene deletions in Aspergillus nidulans: application of the Cre/loxP system 2006 ·Current Genetics ·Josep V. Forment,Daniel Ramón,Andrew MacCabe	41

About Josep V. Forment

Josep V. Forment is a scholar working on Oncology, Aging and Molecular Biology, having authored 30 papers that have together received 2.1k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (18 papers), PARP inhibition in cancer therapy (12 papers) and CRISPR and Genetic Engineering (8 papers). The work is most often cited by research in Molecular Biology (1.8k citations), Aging (37 citations) and Oncology (552 citations). Josep V. Forment has collaborated with scholars based in United Kingdom, Spain and Singapore. Frequent co-authors include Stephen P. Jackson, Abderrahmane Kaidi, Mark J. O’Connor, Sébastien Britton, Raphaël Rodriguez, Blerta Xhemalçe, Charles R. Bradshaw, Mehran Nikan, Shankar Balasubramanian and Kyle M. Miller. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact